Collaboration enhanced the productivity of Biogen's AAV production platform to help accelerate efforts to bring novel gene therapies to patients worldwideBOSTON, Jan. 4, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the successful completion of the gene therapy collaboration they announced with Biogen in May 2021.

合作提高了Biogen AAV生产平台的生产力，以帮助加速为全球患者带来新基因疗法的努力波士顿，2024年1月4日/PRNewswire/--Ginkgo Bioworks（纽约证券交易所：DNA），该平台正在构建细胞编程和生物安全的领先平台，今天宣布，他们于2021年5月宣布与Biogen成功完成了基因治疗合作。

Together, the companies aimed to redefine the industry standard for manufacturing recombinant adeno-associated virus (AAV)-based vectors. The collaboration achieved their goals of enhancing the AAV production titers of Biogen's gene therapy manufacturing processes..

这些公司共同致力于重新定义制造重组腺相关病毒（AAV）载体的行业标准。该合作实现了他们提高Biogen基因治疗制造过程中AAV生产滴度的目标。。

Continue Reading

继续阅读

Ginkgo Bioworks Completes Program with Biogen to Boost Productivity of Gene Therapy Manufacturing Platform

银杏生物工程与Biogen合作完成项目，提高基因治疗制造平台的生产力

'We're proud to work with industry-defining partners like Biogen to help global leaders in the biopharmaceutical industry redefine what's possible in therapeutics discovery and manufacturing,' said Narendra Maheshri, VP Mammalian Engineering at Ginkgo Bioworks. 'Significant improvements like these are the result of a platform-based approach to biological R&D.

银杏生物工程公司哺乳动物工程副总裁纳伦德拉·马赫什里（NarendraMaheshri）说：“我们很荣幸能与Biogen等行业定义合作伙伴合作，帮助生物制药行业的全球领导者重新定义治疗剂发现和制造的可能性。”。“这些重大改进是基于平台的生物研发方法的结果。

They are possible because our program leads work closely with our collaboration partners to take full advantage of the broad scale and deep sophistication of our highly-automated foundry and growing codebase.'.

它们之所以成为可能，是因为我们的项目领导与我们的合作伙伴密切合作，充分利用我们高度自动化的铸造厂和不断增长的代码库的广泛规模和深度复杂性。”。

About Ginkgo Bioworks

关于银杏生物制品

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo's biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity to empower governments, communities, and public health leaders to prevent, detect and respond to a wide variety of biological threats.

银杏生物工程（Ginkgo Bioworks）是细胞编程的领先水平平台，提供灵活的端到端服务，为食品和农业、制药、工业和特种化学品等不同市场的组织解决挑战。银杏生物安全与公共卫生部门（Ginkgo’s biosecurity and public health unit）由银杏（Ginkgo）牵头，正在建设全球生物安全基础设施，以增强政府、社区和公共卫生领导人预防、检测和应对各种生物威胁的能力。

For more information, visit ginkgobioworks.com and concentricbyginkgo.com, read our blog, or follow us on social media channels such as X (formerly known as Twitter) (@Ginkgo and @ConcentricByGBW), Instagram (@GinkgoBioworks and @ConcentricByGinkgo), Threads (@GinkgoBioworks) or LinkedIn.Forward-Looking Statements of Ginkgo BioworksThis press release contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the capabilities and potential success of the partnership and Ginkgo's cell programming platform.

有关更多信息，请访问ginkgobioworks.com和concentricbygingo.com，阅读我们的博客，或通过社交媒体渠道关注我们，如X（以前称为Twitter）（@gingo和@ConcentricByGBW）、Instagram（@ginkgobioworks和@concentricbygingo）、Threads（@ginkgobioworks）或LinkedIn。银杏生物制品的前瞻性声明本新闻稿包含联邦证券法含义内的某些前瞻性声明，包括关于合作伙伴关系和银杏细胞编程平台的能力和潜在成功的声明。

These forward-looking statements generally are identified by the words 'believe,' 'can,' 'project,' 'potential,' 'expect,' 'anticipate,' 'estimate,' 'intend,' 'strategy,' 'future,' 'opportunity,' 'plan,' 'may,' 'should,' 'will,' 'would,' 'will be,' 'will continue,' 'will likely result,' and similar expressions.

这些前瞻性陈述通常由“相信”、“可以”、“项目”、“潜力”、“期望”、“预期”、“估计”、“打算”、“战略”、“未来”、“机会”、“计划”、“可能”、“应该”、“将会”、“将会”、“将会”、“将会继续”、“可能的结果”以及类似的表述来识别。

Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) volatility in the price of .

前瞻性陈述是基于当前预期和假设的关于未来事件的预测、预测和其他陈述，因此会受到风险和不确定性的影响。许多因素可能导致实际的未来事件与本新闻稿中的前瞻性声明存在重大差异，包括但不限于：（i）价格波动。